Related Experiment Video
Updated: Jan 30, 2026

Orthotopic Implantation of Patient-Derived Cancer Cells in Mice Recapitulates Advanced Colorectal Cancer
Published on: February 10, 2023
Relationship between Sarcopenia and mTOR Pathway in Patients with Colorectal Cancer: Preliminary Report
Sílvia Fernandes Maurício1, Simone de Vasconcelos Generoso1, Érica Leandro Marciano Vieira1
1a Universidade Federal de Minas Gerais , Belo Horizonte , Brazil.
Abstract:
Sarcopenia is a syndrome characterized by loss of muscle mass and strength that impacts clinical outcomes and mortality in cancer patients. Although the molecular pathways involved in sarcopenia are not fully elucidated, the decrease in protein synthesis rate appears to be one of the most important events. The objective of this study was to investigate the relationship between sarcopenia and mTOR signaling pathway in patients undergoing colorectal resection surgery. Three groups of patients were assessed: 1) the control group (no cancer, no sarcopenia), 2) the cancer non-sarcopenic group and 3) the cancer sarcopenic group. All individuals were evaluated in relation to presence of sarcopenia and mTOR signaling pathway. Sarcopenia was evaluated by the combination of low muscle mass and low muscle strength, measured using computerized tomography images, and hand grip strength, respectively. Rectus abdominis muscle biopsy was performed at the time of surgery. mTOR pathway was analyzed by MILLIPLEX Map Kit Phospho/total mTOR 2-Plex Magnetic Bead Panel. Results were presented by phosphor/total mTOR ratio. Independent T test, Kruskal-Wallis test, and Dunn-Bonferroni post hoc were performed for statistical analysis and P < 0.05 was considered. Thirty-six patients and five controls were evaluated. A total of 13 cancer patients (36.1%) had sarcopenia. The phospho/total mTOR ratio was different between the control group (0.167 MFI) and the cancer non-sarcopenic group (0.055 MFI) (P = 0.026) as well as between the control group (0.167 MFI) and the cancer sarcopenic group (0.0049 MFI) (P = 0.041). No difference was observed on the median phospho/total mTOR ratio between the cancer groups (P > 0.05). More research is needed to extrapolate these results.
Insights
Sarcopenia, a loss of muscle mass and strength, impacts cancer patients. This study found differences in the mTOR signaling pathway between controls and cancer patients, but not between cancer patients with or without sarcopenia.
Area of Science:
- Oncology
- Molecular Biology
- Geriatrics
Background:
- Sarcopenia is a critical condition in cancer patients, affecting outcomes and mortality.
- Decreased protein synthesis is a key molecular event in sarcopenia, with the mTOR signaling pathway implicated.
- Understanding sarcopenia's molecular basis is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the relationship between sarcopenia and the mTOR signaling pathway in patients undergoing colorectal resection.
- To compare mTOR pathway activity in control, cancer non-sarcopenic, and cancer sarcopenic groups.
Main Methods:
- Sarcopenia assessment involved computerized tomography for muscle mass and hand grip strength.
- Rectus abdominis muscle biopsy was performed during surgery.
- The mechanistic target of rapamycin (mTOR) signaling pathway was analyzed using a MILLIPLEX Map Kit, measuring the phospho/total mTOR ratio.
Main Results:
- Sarcopenia was present in 36.1% of cancer patients.
- A significant difference in the phospho/total mTOR ratio was observed between the control group and both cancer groups (non-sarcopenic and sarcopenic).
- No significant difference in the phospho/total mTOR ratio was found between cancer patients with and without sarcopenia.
Conclusions:
- The mTOR signaling pathway is altered in cancer patients compared to healthy individuals.
- Further research is required to fully elucidate the role of the mTOR pathway in cancer-associated sarcopenia and its clinical implications.
More Related Videos
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Relationship Formation
Data Reporting and Recording
Ending Relationships
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...

